Literature DB >> 19336269

Mortality indicators among chronic Chagas patients living in an endemic area.

José Geraldo Ferreira Gonçalves1, Valdo José Dias Silva, Maria Cândida Calzada Borges, Aluízio Prata, Dalmo Correia.   

Abstract

BACKGROUND: Chagas disease is a serious social-medical problem in Latin American countries because of its high incidence, morbidity and mortality. Our aim was to identify, from demographic, personal history, clinical and electrocardiographic variables, those that might have independent prognostic value regarding mortality, among a population of chronic Chagas patients from a single endemic area where vector transmission has been halted. METHODS AND
RESULTS: Over a mean of 18.5 years, we followed up a prospective cohort of 120 individuals with chronic Chagas disease. Twenty dichotomous variables with prognostic potential for chronic Chagas disease patients were initially evaluated using the Cox model (univariable analysis), to calculate the proportional mortality risk from all causes, cardiovascular causes and sudden death, relative to each variable separately. Of these, 12 variables presenting statistical significance (p<0.05) were included in a multivariable model to determine which of them would have independent prognostic value regarding mortality. Over the follow-up, there were 42 deaths. Eight variables were proven to be independent prognostic factors for mortality, in relation to the three types of death analysed: age ≥39 years, black skin colour, high-degree right-branch block, anterosuperior division block of the left branch, high-degree right-branch block associated with anterosuperior division block of the left branch, high-degree left-branch block, polymorphic ventricular extrasystoles and PR interval ≥0.16 s.
CONCLUSIONS: The presence on conventional electrocardiograms of polymorphic ventricular extrasystoles or high-degree left-branch block, among a population of chronic Chagas patients, constitutes the most important independent factor for poor prognosis.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19336269     DOI: 10.1016/j.ijcard.2009.02.011

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

2.  Purinergic ecto-enzymes participate in the thromboregulation in acute in mice infection by Trypanosoma cruzi.

Authors:  Guilherme M do Carmo; Pedro H Doleski; Mariângela F de Sá; Thirssa H Grando; Nathieli B Bottari; Daniela B R Leal; Lucas T Gressler; Ricardo E Mendes; Lenita M Stefani; Silvia G Monteiro; Aleksandro S Da Silva
Journal:  Mol Cell Biochem       Date:  2017-03-11       Impact factor: 3.396

3.  Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.

Authors:  Antonio B Fernandez; Maria Carmo P Nunes; Eva H Clark; Aaron Samuels; Silvio Menacho; Jesus Gomez; Ricardo W Bozo Gutierrez; Thomas C Crawford; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

4.  Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease.

Authors:  Viviane do Carmo Gonçalves Souza; Karine B Schlemmer; Cristiano B Noal; Jeandre A S Jaques; Margarete D Bagatini; Victor C Pimentel; Luiz Felipe D Carli; Cláudio A M Leal; Juliana Fleck; Maria B Moretto; Maria R C Schetinger; Daniela B R Leal
Journal:  Purinergic Signal       Date:  2012-07-01       Impact factor: 3.765

5.  Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Carolina T Macedo; Ticiana F Larocca; Márcia Noya-Rabelo; Roque Aras; Cristiano R B Macedo; Moisés I Moreira; Alessandra C Caldas; Jorge A Torreão; Victor M A Monsão; Clarissa L M Souza; Juliana F Vasconcelos; Milena R Bezerra; Daniela P Petri; Bruno S F Souza; Antônio G F Pacheco; André Daher; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Front Cardiovasc Med       Date:  2022-06-09

Review 6.  Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger.

Authors:  Reinaldo Bulgarelli Bestetti; Edimar Alcides Bocchi; Renato Bestetti; Victor Sarli Issa; Rosemary Aparecida Furlan-Daniel; Marcelo Arruda Nakazone
Journal:  Front Med (Lausanne)       Date:  2022-06-29

Review 7.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

8.  Genetic and functional role of TNF-alpha in the development Trypanosoma cruzi infection.

Authors:  Cristina Wide Pissetti; Dalmo Correia; Rafael Faria de Oliveira; Maurício Manoel Llaguno; Marly Aparecida Spadotto Balarin; Roseane Lopes Silva-Grecco; Virmondes Rodrigues
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

9.  Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007.

Authors:  Francisco Rogerlândio Martins-Melo; Carlos Henrique Alencar; Alberto Novaes Ramos; Jorg Heukelbach
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14

10.  Predictive factors for the progression of chronic Chagas cardiomyopathy in patients without left ventricular dysfunction.

Authors:  Silvana de Araújo Silva; Eliane Dias Gontijo; João Carlos Pinto Dias; Camila Gomes de Souza Andrade; Carlos Faria Santos Amaral
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.